Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Chattanooga
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Chattanooga, TN

Studies commonly pay $75 to $4,500 per completed study

146 clinical trials are currently recruiting participants within 30 miles of Chattanooga. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

146studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Chattanooga right now

Top 25 of 146 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
Chattanooga Medical Research /ID# 257631 — Chattanooga, Tennessee (3.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06345339)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
Nephrology & Hypertension Specialists — Dalton, Georgia (25.8 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Memorial Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Breast Cancer, Triple Negative Breast Cancer Phase 2 Interventional 110 participants sought
Sarah Cannon Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Dana-Farber Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT04468061)

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1, Phase 2 Interventional 754 participants sought
Tennessee Oncology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05379985)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Southeastern Retina Associates — Hixson, Tennessee (5.2 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought
Chattanooga Medical Research, Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: pH-D Feminine Health LLC
See eligibility & contact on ClinicalTrials.gov (NCT07109869)

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Multiple Myeloma Phase 1, Phase 2 Interventional 123 participants sought
GSK Investigational Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT05714839)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Tennessee Oncology, PLLC - Chattanooga Downtown — Chattanooga, Tennessee (3.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Phase 3 Interventional 1,410 participants sought
Tennessee Oncology, PLLC - Chattanooga Downtown — Chattanooga, Tennessee (3.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222566)

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 600 participants sought
Site 60 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merus B.V.
See eligibility & contact on ClinicalTrials.gov (NCT06496178)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

B-cell Malignancy, Marginal Zone Lymphoma Phase 1, Phase 2 Interventional 645 participants sought
Tennesse Oncology Chattanooga Downtown — Chattanooga, Tennessee (3.8 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT05006716)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06318169)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 2 Interventional 60 participants sought
Investigator Site #4 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Akebia Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07268638)

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis Phase 3 Interventional 1,590 participants sought
ClinSearch, LLC — Chattanooga, Tennessee (3.8 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06632457)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

COVID-19 SARS-CoV-2 Infection Phase 3 Interventional 2,330 participants sought
WR-Clinsearch, LLC — Chattanooga, Tennessee (3.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06679140)

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought
University Diabetes & Endocrine Consultants — Chattanooga, Tennessee (3.8 mi) · Sponsor: Zucara Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05762107)

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 270 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis Phase 2 Interventional 70 participants sought
Erlanger Health System — Chattanooga, Tennessee (3.8 mi) · Sponsor: argenx
See eligibility & contact on ClinicalTrials.gov (NCT07284420)

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Stereotypical Prolonged Seizures Phase 3 Interventional 350 participants sought
Ep0162 50700 — Chattanooga, Tennessee (3.8 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT05077904)

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Neoplasms, Head and Neck Phase 3 Interventional 864 participants sought
GSK Investigational Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06256588)

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Agitation, Alzheimer Disease Phase 2 Interventional 120 participants sought
Local Institution - 0031 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT06808984)
Actively enrolling

Studies you may be able to join near Chattanooga

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Chattanooga

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

M3 Wake Research Chattanooga

★ 4.5
6035 Shallowford Rd, Chattanooga, TN 37421
(423) 698-4584
"Great friendly staff, get paid for participating in qualified medical research."
— Tyler Yeager, 5★

Nova Research Trials

725 Glenwood Dr Ste 686, Chattanooga, TN 37404
(423) 703-0888

Lynn Institute of Chattanooga

Located in the Missionary Ridge Medical Tower, 725 Glenwood Dr #888, Chattanooga, TN 37404
(423) 713-5966

Chattanooga Research & Medicine

2205 McCallie Ave Ste 301, Chattanooga, TN 37404
(423) 643-2253

Chattanooga Medical Research

★ 5.0
929 Spring Creek Rd, Chattanooga, TN 37412
(423) 648-7794

Wilkins Research Services

★ 4.0
1730 Gunbarrel Rd, Chattanooga, TN 37421
(423) 894-9478
"I had my very first focus group today and I was nervous since I have never done anything like his before. They were extremely sweet, offered us drink…"
— Leila Parker, 5★

Erlanger Endocrinology

★ 2.3
979 E 3rd St Ste A-550, Chattanooga, TN 37403
(423) 778-8224
"Have an appointment today after waiting for 3 months but I haven't been able to get ahold of anyone at the office. They absolutely suck . Please if …"
— sticky mess, 1★

Southeast Clinical Research Center

1102 W Waugh St, Dalton, GA 30720
(706) 913-1779

Scenic City Neurotherapy and Ketamine Center

★ 4.9 (82 reviews)
7405 Shallowford Rd STE 240, Chattanooga, TN 37421
(423) 228-0579
"Exceptional staff across the board. Charles and Brian are incredible providers, Connie, the receptionist is a joy to talk to and be welcomed by every…"
— James Dietzen, 5★

Clinical trials in Chattanooga: what's recruiting

The Chattanooga area currently has 146 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Chattanooga, the most active research areas are:

  • Cancer & Oncology9 studies
  • Liver & Kidney5 studies
  • Diabetes & Metabolism4 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Chattanooga, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Chattanooga

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Chattanooga participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Chattanooga pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Chattanooga?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Chattanooga safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Chattanooga?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Chattanooga

Other metros within reach

Murfreesboro, TN77 Huntsville, AL92 Atlanta, GA1,710 Knoxville, TN231 Gainesville, GA157 Nashville, TN1,342 Birmingham, AL966 Athens, GA74

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Chattanooga Bladder Issues Due To Spinal Cord Injury in Chattanooga All conditions

More of TN

Nashville1,342 Memphis580 Knoxville231 Murfreesboro77 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts